In my last article I had mentioned about Sanofi Aventis generic market penetration in emerging markets, today morning the news was that Sanofi is interested in venturing into Ophthalmology domain and in the news it was also mentioned that last year as it had closed 33 deals it is going to close the same number of deals by this year end......An interesting observation is that last year Abbott was the company which had invested heavily in Ophthalmology segment but this year with Sanofi eyeing this therapeutic landscape we will have tough neck to neck competition between the two giants in Ophthalmology therapy landscape in the coming decade.
Read more in http://www.forexyard.com/en/news/Sanofi-RD-sets-sight-on-eye-diseases-2010-06-03T081726Z-INTERVIEW
No comments:
Post a Comment